SCHEMBL4757018

SCHEMBL4757018

CC(C)S(=O)(=O)c1csc(NC(=O)c2cc(O)cc(Cl)c2)n1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GCK P35557 3/20 0.45
GRM5 P41594 2/20 0.45
CYP3A4 P08684 1/20 0.43
ADORA3 P0DMS8 1/20 0.39
RORC P51449 1/20 0.39
MAPT P10636 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CTPS1 P17812 1/20 0.37
HSD17B1 P14061 1/20 0.36
TYR P14679 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257681 0.82 GRM5 (0.44) GCKGRM5CYP3A4ADORA3RORC
SCHEMBL4757228 0.81 HSD17B10 (0.47) GCKGRM5ADORA3RORCMAPT
SCHEMBL10114414 0.79 GRM5 (0.68) GCKGRM5CYP3A4MAPTNPC1
SCHEMBL4757029 0.78 RAB9A (0.50) GCKGRM5MAPTNPC1RAB9A
SCHEMBL4756908 0.77 FFAR2 (0.40) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL13951759 0.75 GRM5 (0.46) GCKGRM5CYP3A4ADORA3MAPT
SCHEMBL12994107 0.73 NPC1 (0.63) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL704070 0.69 KDM4A (0.54) GCKGRM5MAPTNPC1RAB9A
SCHEMBL703145 0.68 RAB9A (0.60) ADORA3MAPTNPC1RAB9AMEN1
SCHEMBL10114276 0.67 RAB9A (0.60) MAPTNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC GCK 1360/4885GRM5 4521/4885CYP3A4 1087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.